Table 1.

Baseline characteristics of the 2009 patients included in analyses

No. of females (%)	1283 (63.9%)
Region (%)
Africa	1631 (81.2%)
South America	378 (18.8%)
Age (years)
Median (IQR)	34 (30–41)
CD4 cell count (cells/μl)
Median (IQR)	101 (44–168)
No. missing (%)	214 (10.7%)
HIV-1 viral load (log10 copies/ml)
Median (IQR)	5.0 (4.5–5.5)
No. missing (%)	441 (22.0%)
Clinical stage
CDC stage C, WHO stage III/IV	1338 (71.9%)
No. missing (%)
Year of starting ART	149 (7.4%)
Median (IQR)	2004 (2003–2004)
ART regimen
3CT d4T EFV	925 (46.0%)
3CT AZT EFV	588 (29.3%)
3TC d4T NVP	236 (11.8%)
Other	260 (12.9%)

IQR, interquartile range; ART, antiretroviral therapy.